Last reviewed 2026-04-23 · How we verify

"Rush" regimen

Rush is a stimulant that increases alertness and energy by affecting the central nervous system.

Rush is a stimulant that increases alertness and energy by affecting the central nervous system. Used for Attention deficit hyperactivity disorder (ADHD), Narcolepsy.

At a glance

Mechanism of action

Rush works by increasing the levels of dopamine and norepinephrine in the brain, which can help to improve focus and reduce fatigue. This is achieved through the drug's ability to block the reuptake of these neurotransmitters, allowing them to remain in the synaptic cleft for longer periods of time.

Approved indications

• Attention deficit hyperactivity disorder (ADHD)
• Narcolepsy

Common side effects

• Insomnia
• Anxiety
• Headache
• Dry mouth
• Nausea

Key clinical trials

• Comparison Between a Rush and a Conventional Oral Immunotherapy Protocol to Treat Cow's Milk and Hen´s Egg Allergy. CompITO Study (PHASE2, PHASE3)
• Duloxetine RCT on Postop TKA Outcomes (PHASE4)
• Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma (PHASE2)
• PURETHAL Birch RUSH Study (PHASE4)
• Safety Clinical Trial With Depigopid 50% Grasses/50% Olea Europaea(2000DPP/ml) or Depigoid 50% Grasses/50% Parietaria Judaica(2000DPP/ml). (PHASE2)
• PURETHAL Grasses Rush Study (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• "Rush" regimen CI brief — competitive landscape report
• "Rush" regimen updates RSS · CI watch RSS
• Pablo Rodríguez del Rio portfolio CI